MedTrace Logo

Effect of Using a Reminder to Encourage Patients to be Active During Their Hospital Stay.

NCT07492745 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2026-06-16

No results posted yet for this study

Summary

Around 30% of patients aged 65 and over experience functional decline due to hospitalization. Physical inactivity, often without medical justification, is common during hospital stays.This immobility leads to loss of autonomy, muscle strength, and increases post-discharge risks.

Slow walking for 25-40 minutes daily significantly improves functional capacity. However, it could be difficult to reach this time of walking due to a lack of physiotherapist in hospital.

A vibrating watch may encourage patients to walk or perform strengthening exercises. This simple intervention aims to improve function without requiring additional staff or resources

Conditions

  • Inpatients
  • Frail

Interventions

DEVICE

Vibrating reminder

The exercises will be prescribed according to the patient's physical abilities and environmental constraints. A vibrating reminder will be given to the patient, set to go off six times a day.

DEVICE

Control group

The exercises will be prescribed according to the patient's physical abilities and environmental constraints. A vibrating reminder will be given to the patient, set to go off once time a day.

Sponsors & Collaborators

  • Centre Hospitalier de Valence

    collaborator OTHER

  • Centre Hospitalier of Chartres

    collaborator OTHER

  • Groupe Hospitalier du Havre

    lead OTHER

Principal Investigators

  • Léa Bansard, PT, MSc · Groupe Hospitalier du Havre

  • Guillaume Prieur, PT, PhD · Groupe Hospitalier du Havre

  • Yann Combret, PT, PhD · Groupe Hospitalier du Havre

  • Clément Medrinal, Prof. · Groupe Hospitalier du Havre

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-19
Primary Completion
2028-10-01
Completion
2029-01-01

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07492745 on ClinicalTrials.gov